Track the 페니트리움바이오 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 페니트리움바이오 has logged 50 public disclosures. Market capitalisation: €285.9bn. The latest transaction was filed on 4 September 2026 (Purchase). Among the most active insiders: 모비스. The full history is openly available.
43
Insider Decl.
n/a
Thresholds
n/a
13 ops.
Buy Volume
n/a
13 ops.
Sell Volume
Fundamental score
Ranked 27,874 of 29,064 companies
14.5
score / 100
Value
26
Quality
3
FCF yld-1.8%
Earn yld-5.2%
EV/EBITDA·
ROE-89%
Gross mgn0.4%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
페니트리움바이오 opera en el sector de la salud y farmacéutico, cotizando en el mercado XKRX. La empresa se enfoca en el desarrollo de soluciones biofarmacéuticas innovadoras.